drugset / Trial / NCT06610071
NIFR Image-guided Surgery for Malignant Soft Tissue Tumor With Low-dose SWIG Technique
Phase 1
Not yet recruiting
592 enrolled
The Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Chinese PLA General Hospital · collabPeking University International Hospital · collabPeking University Third Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This research study will evaluate how near-infrared fluorescence (NIRF) imaging with low-dose second window indocyanine green (ICG) can assist in the radical resection and pathologic diagnosis of malignant soft tissue sarcoma, such as dermatofibrosarcoma protuberans (DFSP) and skin squamous cell carcinoma (sSCC) during surgery.
Timeline
- Start
- 2024-10-30
- Primary completion
- 2028-12
- Completion
- 2030-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ICG administration | Unknown | 0.25 mg/kg | Intravenous |
| Subject | ICG administration | Unknown | 25 mg | Intravenous |